VivoSeq
Other

Tenosynovitis

11

Pipeline Programs↗

1

Active Trials↗

4

Companies Involved↗

Tenosynovitis is an emerging landscape with 11 programs across 4 companies. The most active players are Pfizer's Upjohn has merged with Mylan to form Viatris Inc., Pfizer, Javelin Pharmaceuticals. 8 therapies are approved.

Intelligence

Pipeline Metrics

Competitive Density

38/100

Pipeline Velocity

0/100

Mech. Concentration

80/100

Completion Rate

80/100

Attrition Rate

17/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

P

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

2 programs

ApprovedPfizer logo

Pfizer

1 program

ApprovedJ

Javelin Pharmaceuticals

1 program

ApprovedQ

Quince Therapeutics S.p.A.

1 program

Preclinical

Pipeline

Programs by Phase

Analysis

Trial Status

6

clinical trials

Completed4 · 67%
Terminated1 · 17%
Recruiting1 · 17%

Clinical Trials

Trial Activity

6 trials

Intra-sheath vs Extra-sheath Injection for De Quervain's Tenosynovitis
Recruiting·UUniversity of California, Davis·Approved·NCT04895956·80 enrolled
Anesthesia Tumescent for Surgical Management of Tenosynovitis.
Completed·IInstituto Mexicano del Seguro Social·N/A·NCT03914235·60 enrolled
Collagen-povidone for Diabetic Seniors' Tenosynovitis
Completed·IInstituto Mexicano del Seguro Social·Phase 4·NCT06396819·25 enrolled
Betamethasone Versus Ketorolac Injection for the Treatment of DeQuervains Tenosynovitis
Completed·OOrthoCarolina Research Institute, Inc.·Phase 4·NCT02604537·64 enrolled
Comparative Effectiveness of Local Corticosteroid Injection and Open Surgical Release for Pain Outcomes in De Quervain Tenosynovitis: A Single-Centre Study
Completed·Rawalpindi Teaching Hospital, District Headquarter Hospital, Rawalpindi·Preclinical·NCT07683429·100 enrolled
Differential Efficacy of Corticosteroid Solutions for Non-Operative Treatment of Digit Flexor Tenosynovitis
Terminated·UUniversity of Missouri-Columbia·Phase 4·NCT04002037·95 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)